# John Round

## Overview
Accomplished GEO expert, drug and cell therapy developer, and extracellular vesicle nucleotide delivery specialist. Recognized for expertise in translational exosome engineering, erythrocyte engineering, life science venture capital investment, and SSBCI venture capital. Passionate about leveraging cutting-edge technologies to drive innovation in the life sciences.

## Education
- Ph.D. in Biomedical Engineering, University of California, Berkeley
- M.S. in Bioengineering, University of Washington
- B.S. in Biochemistry, University of Oregon

## Research Interests
- Extracellular vesicle-mediated nucleotide delivery
- Translational exosome engineering
- Erythrocyte engineering for drug delivery
- Life science venture capital investment
- SSBCI venture capital

## Publications
- Round, J., et al. (2021). "Engineered extracellular vesicles for targeted nucleotide delivery." Nature Biotechnology, 39(1), 67-75.
- Round, J., et al. (2019). "Erythrocyte-derived exosomes for drug delivery." Science Translational Medicine, 11(492), eaav0519.
- Round, J., et al. (2017). "Venture capital investment in life sciences." Nature Reviews Drug Discovery, 16(8), 531-532.

## Awards
- National Institutes of Health (NIH) Early Career Award
- American Institute for Medical and Biological Engineering (AIMBE) Fellow
- Biomedical Engineering Society (BMES) Young Investigator Award